
NMN Capsules vs. NAD+ IV Drips: Which Is Right for You?
Share
There is growing awareness of the importance of NAD+ (nicotinamide adenine dinucleotide). Two popular methods of raising NAD+ levels have emerged: NMN capsules and intravenous NAD+ drips.
What’s the Difference?
NAD+ IV drips deliver the NAD+ molecule directly into the bloodstream through an intravenous infusion. Sessions typically last 1–2 hours and are administered in clinics or wellness centres.
NMN capsules, by contrast, deliver Nicotinamide Mononucleotide, a direct precursor to NAD+ that can be absorbed through the gut. Once ingested, NMN is quickly converted into NAD+ within cells, especially in tissues like the liver and muscle [1].
Benefits & Drawbacks
IV drips provide immediate systemic NAD+ and may be beneficial for people with significant depletion [2]. However, they require needles, time, and recurring clinic visits, and incur higher costs of around £200–£500 per session.
Capsules are non-invasive, affordable, and can be taken daily at home to support consistent NAD+ levels over time. At ānjīn, our slow-release NMN capsules are designed for steady absorption and maximum bioavailability — no needles required.
Cost and Convenience
NMN Capsules: ~£0.5–1 per day
NAD⁺ Drips: ~£200+ per session
While IV therapy may benefit some people, NMN offers a sustainable, long-term approach to NAD+ support at a fraction of the cost.
Stability and Storage
One key to NMN effectiveness is stability. Research shows NMN may be affected by heat and humidity [3], so always store your capsules in a cool, dry place, away from sunlight.
Which One is Right for You?
If you’re needle-averse, cost-conscious, or want daily, low effort NAD+ support, NMN capsules are likely your best bet. For those with unique clinical needs IV therapy might play a role, you should always consult your doctor before undertaking a new therapy.
In the end, it's about choosing what fits your body, lifestyle, and goals.
References
[1] Grozio et al., Nature Communications, 2019
[2] Grant et al., Frontiers in Aging Neuroscience, 2022
[3] Mills et al., Cell Reports, 2016